ChemR23 knockout mice display mild obesity but no deficit in adipocyte differentiation

Journal of Endocrinology

Volumn 219, Issue 3, 2013, Pages 279-289

  Rouger, Laurie ^a   Denis, G Raphaël ^b   Luangsay, Souphalone ^a,c   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c Euroscreen SA   (Belgium)

Author keywords

Adipokines; G protein coupled receptor; Inflammation

Indexed keywords

CHEMERIN; CHEMR23 PROTEIN; LIPID; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL FUNCTION; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE TOLERANCE; IN VIVO STUDY; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; LIPID DIET; LIPOGENESIS; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; OBESITY; PHENOTYPE; PRIORITY JOURNAL;

ADIPOKINES; G-PROTEIN-COUPLED RECEPTOR; INFLAMMATION;

ADIPOGENESIS; ADIPOSE TISSUE, WHITE; ADIPOSITY; AGING; ANIMALS; BIOLOGICAL MARKERS; CHEMOTACTIC FACTORS; DIET, HIGH-FAT; FEMALE; GLYCEROLPHOSPHATE DEHYDROGENASE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LIPOGENESIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OBESITY; OVERWEIGHT; RECEPTORS, G-PROTEIN-COUPLED; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; WEIGHT GAIN;

EID: 84890155705     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-13-0106     Document Type: Article

References (35)

1. Arch JR, Hislop D, Wang SJ & Speakman JR 2006 Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. International Journal of Obesity 30 1322-1331.
2. Bauer S, Wanninger J, Schmidhofer S, Weigert J, Neumeier M, Dorn C, Hellerbrand C, Zimara N, Schaffler A, Aslanidis C et al. 2011 Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes. Endocrinology 152 26-35.
3. Bondue B, Wittamer V & ParmentierM 2011 Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism. Cytokine & Growth Factor Reviews 22 331-338.
4. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K & Segal D 2007 Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 148 4687-4694.
5. Bozaoglu K, Segal D, Shields KA, Cummings N, Curran JE, Comuzzie AG, Mahaney MC, Rainwater DL, VandeBerg JL, MacCluer JW et al. 2009 Chemerin is associated with metabolic syndrome phenotypes in a Mexican-American population. Journal of Clinical Endocrinology and Metabolism 94 3085-3088.
6. Dong B, Ji W & Zhang Y 2011 Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with metabolic syndrome. Internal Medicine 50 1093-1097.
7. Ernst MC & Sinal CJ 2010 Chemerin: at the crossroads of inflammation and obesity. Trends in Endocrinology and Metabolism 21 660-667.
8. Ernst MC, Issa M, Goralski KB & Sinal CJ 2010 Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151 1998-2007.
9. Ernst MC, Haidl ID, Zuniga LA, Dranse HJ, Rourke JL, Zabel BA, Butcher EC & Sinal CJ 2012 Disruption of the chemokine-like receptor-1 (CMKRL1) is associated with reduced adiposity and glucose intolerance. Endocrinology 153 672-682.
10. Galic S, Oakhill JS & Steinberg GR 2010 Adipose tissue as an endocrine organ. Molecular and Cellular Endocrinology 316 129-139.
11. Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, Zhang X, Wang L & Tao H 2011 Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovascular Diabetology 10 87.
12. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S & Sinal CJ 2007 Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. Journal of Biological Chemistry 282 28175-28188.
13. Hu E, Liang P & Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. Journal of Biological Chemistry 271 10697-10703.
14. Karlsson EA & Beck MA 2010 The burden of obesity on infectious disease. Experimental Biology and Medicine 235 1412-1424.
15. Lehrke M, BeckerA,Greif M, Stark R, Laubender RP, von Ziegler F, LebherzC, Tittus J, Reiser M, Becker C et al. 2009 Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis. European Journal of Endocrinology 161 339-344.
16. Luangsay S, Wittamer V, Bondue B, De Henau O, Rouger L, Brait M, Franssen JD, de Nadai P, Huaux F & Parmentier M 2009 Mouse ChemR23 is expressed in dendritic cell subsets and macrophages, and mediates an anti-inflammatory activity of chemerin in a lung disease model. Journal of Immunology 183 6489-6499.
17. MacDougald OA & Burant CF 2007 The rapidly expanding family of adipokines. Cell Metabolism 6 159-161.
18. Maffei M, Fei H, Lee GH, Dani C, Leroy P, Zhang Y, Proenca R, Negrel R, Ailhaud G & Friedman JM 1995 Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus. PNAS 92 6957-6960.
19. Muruganandan S, Parlee SD, Rourke JL, Ernst MC, Goralski KB & Sinal CJ 2010 Chemerin, a novel peroxisome proliferator-activated receptor g (PPARg) target gene that promotes mesenchymal stem cell adipogenesis. Journal of Biological Chemistry 286 23982-23995.
20. Muruganandan S, Roman AA & Sinal CJ 2011 Role of chemerin/CMKLR1 signaling in adipogenesis and osteoblastogenesis of bone marrow stem cells. Journal of Bone and Mineral Research 25 222.
21. Mussig K, Staiger H, Machicao F, Thamer C, Machann J, Schick F, Claussen CD, Stefan N, Fritsche A & Haring HU 2009 RARRES2 encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: a comparative magnetic resonance imaging study. Metabolism 58 519-524.
22. Ouchi N, Parker JL, Lugus JJ & Walsh K 2011 Adipokines in inflammation and metabolic disease. Nature Reviews. Immunology 11 85-97.
23. Parlee SD, Ernst MC, Muruganandan S, Sinal CJ & Goralski KB 2010 Serum chemerin levels vary with time of day and are modified by obesity and tumor necrosis factor-a. Endocrinology 151 2590-2602.
24. Pi-Sunyer FX 2002 The obesity epidemic: pathophysiology and consequences of obesity. Obesity Research 10(Suppl 2) 97S-104S.
25. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M & Sasaki S 2007 Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochemical and Biophysical Research Communications 362 1013-1018.
26. Sell H, Divoux A, Poitou C, Basdevant A, Bouillot JL, Bedossa P, Tordjman J, Eckel J & Clement K 2010 Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery. Journal of Clinical Endocrinology and Metabolism 95 2892-2896.
27. Spiroglou SG, Kostopoulos CG, Varakis JN & Papadaki HH 2010 Adipokines in periaortic and epicardial adipose tissue: differential expression and relation to atherosclerosis. Journal of Atherosclerosis and Thrombosis 17 115-130.
28. Sul HS 2009 Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate. Molecular Endocrinology 23 1717-1725.
29. Sul HS, Smas C, Mei B & Zhou L 2000 Function of pref-1 as an inhibitor of adipocyte differentiation. International Journal of Obesity and Related Metabolic Disorders 24(Suppl 4) S15-S19.
30. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S et al. 2008 Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Letters 582 573-578.
31. Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Schaffler A, Aslanidis C et al. 2010 Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clinical Endocrinology 72 342.
32. Weir JB 1949 New methods for calculating metabolic rate with special reference to protein metabolism. Journal of Physiology 109 1-9.
33. Winzell MS & Ahren B 2004 The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 53(Suppl 3) S215-S219.
34. Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Brezillon S, Tyldesley R, Blanpain C, Detheux M et al. 2003 Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. Journal of Experimental Medicine 198 977-985.
35. Wozniak SE, Gee LL, Wachtel MS & Frezza EE 2009 Adipose tissue: the new endocrine organ? A review article Digestive Diseases and Sciences 54 1847-1856.